Indoco Remedies testing unit clears FDA pre-approval inspection with zero observations

The inspection was conducted by the US Food and Drug Administration between April 8-10. Shares of Indoco Remedies Ltd ended at ₹209.95, up by ₹7.80, or 3.86%, on the BSE today, April 13.

Leave a Reply

Your email address will not be published. Required fields are marked *